[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Coherus Oncology Inc (CHRS)

Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coherus Oncology Inc 333 TWIN DOLPHIN DRIVE SUITE 600 REDWOOD CITY CA 94065 USA

www.coherus.com Employees: 147 P: 650-649-3530

Sector:

Medical

Description:

Coherus is a fully integrated commercial-stage innovative oncology company. Coherus, formerly known as Coherus BioSciences Inc., is based in REDWOOD CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 245,258
Enterprise Value, $K 193,428
Shares Outstanding, K 154,250
Float, K 141,787
% Float 91.92%
Short Interest, K 28,108
Short Float 18.22%
Days to Cover 17.16
Short Volume Ratio 0.60
% of Insider Shareholders 8.08%
% of Institutional Shareholders 72.82%

Financials:

Annual Sales, $ 42,170 K
Annual Net Income, $ 168,020 K
Last Quarter Sales, $ 12,310 K
Last Quarter Net Income, $ -38,330 K
EBIT, $ -171,850 K
EBITDA, $ -167,930 K

Growth:

1-Year Return 110.53%
3-Year Return -64.27%
5-Year Return -88.02%
5-Year Revenue Growth -91.14%
5-Year Earnings Growth -196.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 05/11/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -1.43
EPS Growth vs. Prev Qtr 30.77%
EPS Growth vs. Prev Year 34.15%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 01/16/95
Dividend Payout Ratio 0.00%

CHRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -198.90%
Return-on-Assets % -46.65%
Profit Margin % 398.43%
Debt/Equity 0.47
Price/Sales 6.04
Price/Cash Flow N/A
Price/Book 3.24
Book Value/Share 0.51
Interest Coverage -19.35
60-Month Beta 1.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.